Time is always the ultimate witness, and superior quality always shines with dazzling brilliance. Just as Hippocrates has always adhered to its philosophy of "Creating Health Value through Technology", the company has continued to make strides and gained high recognition and attention from the industry in the field of life and health in recent years.
Recently, the CMIS 3rd China Pharmaceutical Digital and Intelligent Summit was successfully held in Shanghai. Concurrently, the CMIS Annual Award Ceremony was held at the summit, aiming to deeply identify and honor enterprises, elite teams and outstanding individuals that have demonstrated extraordinary wisdom and innovative capabilities amid the wave of digital transformation in the pharmaceutical and health industry. This grand ceremony reflects a profound understanding and forward-looking vision for the in-depth integration of digitalization and intelligentization in the pharmaceutical industry, as well as a keen insight into and deep concern for the future development trends of the industry. By setting up these role models of industry pioneers, the CMIS Annual Award Ceremony has stimulated the innovation vitality and transformation momentum of the entire pharmaceutical industry.
Hippocrates's GMP Document Management System (DMS) has won wide recognition and affirmation in the industry for its outstanding performance and user experience. At the award ceremony, Mr. Tan Jie, Sales Director of Singdi, took the stage on behalf of the company to receive the award. This moment is not only an affirmation of Singdi, but also the best testimony to the unremitting efforts and continuous innovation of our team.
Looking ahead, Hippocrates will continue to keep pace with the development trends of the industry, constantly enhance its digital technology and service capabilities, and contribute to the vigorous development of the life and health industry. We promise to continue to be driven by innovation, lead the future with technology, and provide more solid support for the digital transformation of the pharmaceutical industry.